Literature DB >> 12584752

Lack of serological evidence for an association between simian virus 40 and lymphoma.

Silvia de Sanjose1, Keerti V Shah, Eva Domingo-Domenech, Eric A Engels, Alberto Fernandez de Sevilla, Tomas Alvaro, Mercedes Garcia-Villanueva, Vicens Romagosa, Eva Gonzalez-Barca, Raphael P Viscidi.   

Abstract

Recent studies have implicated simian virus 40 (SV40) in non-Hodgkin's lymphomas based on detection of SV40 DNA sequences. We employed a virus-like-particle (VLP)-based enzyme immunoassay for antibodies to SV40 to test sera from 520 lymphoma cases and 587 controls in Spain. The SV40 seroprevalence was 9.5% in controls and 5.9% in cases. Antibody levels of the positive sera were low. There was no association of SV40 seropositivity with any subtype of lymphoma. VLPs of the human BK virus substantially inhibited the SV40 reactivity of human sera. There was no serological evidence of widespread SV40 infection and no association of SV40 seropositivity with human lymphomas in Spain. Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12584752     DOI: 10.1002/ijc.10993

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  8 in total

1.  Non-Hodgkin Lymphoma, Body Mass Index, and Cytokine Polymorphisms: A Pooled Analysis from the InterLymph Consortium.

Authors:  Eleanor Kane; Christine F Skibola; Paige M Bracci; James R Cerhan; Laura Costas; Karin Ekström Smedby; Elizabeth A Holly; Marc Maynadié; Anne J Novak; Tracy J Lightfoot; Stephen M Ansell; Alex G Smith; Mark Liebow; Mads Melbye; Lindsay Morton; Silvia de Sanjosé; Susan L Slager; Sophia S Wang; Yawei Zhang; Tongzhang Zheng; Eve Roman
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2015-05-11       Impact factor: 4.254

2.  Identification of species-specific and cross-reactive epitopes in human polyomavirus capsids using monoclonal antibodies.

Authors:  Parmjeet Randhawa; Raphael Viscidi; Joseph J Carter; Denise A Galloway; Tim D Culp; Cathy Huang; Bala Ramaswami; Neil D Christensen
Journal:  J Gen Virol       Date:  2009-03       Impact factor: 3.891

3.  Non-Hodgkin lymphoma and obesity: a pooled analysis from the InterLymph Consortium.

Authors:  Eleanor V Willett; Lindsay M Morton; Patricia Hartge; Nikolaus Becker; Leslie Bernstein; Paolo Boffetta; Paige Bracci; James Cerhan; Brian C-H Chiu; Pierluigi Cocco; Luigino Dal Maso; Scott Davis; Silvia De Sanjose; Karin Ekstrom Smedby; Maria Grazia Ennas; Lenka Foretova; Elizabeth A Holly; Carlo La Vecchia; Keitaro Matsuo; Marc Maynadie; Mads Melbye; Eva Negri; Alexandra Nieters; Richard Severson; Susan L Slager; John J Spinelli; Anthony Staines; Renato Talamini; Martine Vornanen; Dennis D Weisenburger; Eve Roman
Journal:  Int J Cancer       Date:  2008-05-01       Impact factor: 7.396

4.  Investigation of pre-diagnostic virological markers for progressive multifocal leukoencephalopathy in human immunodeficiency virus-infected patients.

Authors:  Mary K Grabowski; Raphael P Viscidi; Joseph B Margolick; Lisa P Jacobson; Keerti V Shah
Journal:  J Med Virol       Date:  2009-07       Impact factor: 2.327

5.  Mesothelioma mortality in Europe: impact of asbestos consumption and simian virus 40.

Authors:  Katharina Leithner; Andreas Leithner; Heimo Clar; Andreas Weinhaeusel; Roman Radl; Peter Krippl; Peter Rehak; Reinhard Windhager; Oskar A Haas; Horst Olschewski
Journal:  Orphanet J Rare Dis       Date:  2006-11-07       Impact factor: 4.123

Review 6.  Association Between Simian Virus 40 and Human Tumors.

Authors:  John Charles Rotondo; Elisa Mazzoni; Ilaria Bononi; Mauro Tognon; Fernanda Martini
Journal:  Front Oncol       Date:  2019-07-25       Impact factor: 6.244

7.  The Prognostic Role and Relationship between E2F1 and SV40 in Diffuse Large B-Cell Lymphoma of Egyptian Patients.

Authors:  Rehab M Samaka; Hayam A Aiad; Mona A Kandil; Nancy Y Asaad; Nanes S Holah
Journal:  Anal Cell Pathol (Amst)       Date:  2015-10-27       Impact factor: 2.916

Review 8.  How Simian Virus 40 Hijacks the Intracellular Protein Trafficking Pathway to Its Own Benefit … and Ours.

Authors:  Miguel G Toscano; Peter de Haan
Journal:  Front Immunol       Date:  2018-05-28       Impact factor: 7.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.